compound, pharmaceutical formulation, method for treating or preventing lipid disorders (dyslipidemia) associated or not with insulin resistance, use of compound, method for treating or preventing type 2 diabetes, and, pharmaceutical composition

摘要

COMPOUND, PHARMACEUTICAL FORMULATION, METHOD FOR TREATING OR PREVENTING LIPID DISORDERS (DYSIPIPIDEMIA) ASSOCIATED WITH OR NOT WITH RESISTANCE TO INSULIN, USE OF COMPOUND, METHOD TO TREAT OR PREVENT DIABETES, TYPE 2DIABETES, A tert-butylamine salt, a piperazine salt, a choline salt, a tris (hydroxymethyl) methylamine salt, a lysine salt or an adamantylamine salt (-) - 2- {¢ 2- (-) - 2- {4 - 2- (4-Hydroxy-phenyl) -thio} -3- (4-hydroxyethylthio} -3- ¢ 4- (2- {4-adamantylamide of acid) - ¢ 4- (2- {4- (methylsulfonyl) oxy-phenoxy} ethyl) -phenyl-propanoic, processes for their preparation, their use in the treatment of clinical conditions including lipid disorders (dyslipidemias) ), whether or not associated with insulin resistance and other manifestations of metabolic syndrome, and pharmaceutical compositions containing them.